References
-
1
Wehrmann T, Seifert H, Hagenmüller F. et al .
Endoscopic sphincter of Oddi manometry - does skepticism vanish?.
Z Gastroenterol.
1996;
34
17-25
-
2
Allescher H D.
Clinical impact of sphincter of Oddi dyskinesia.
Endoscopy.
1998;
30 (Suppl 2)
231-236
-
3
Tzovaras G, Rowlands B J.
Diagnosis and treatment of sphincter of Oddi dysfunction.
Br J Surg.
1998;
85
588-595
-
4
Wehrmann T, Stergiou N, Riphaus A, Lembcke B.
Correlation between sphincter of Oddi manometry and intraductal ultrasound morphology in patients with suspected sphincter of Oddi dysfunction.
Endoscopy.
2001;
33
773-777
-
5
Guelrud M, Mendoza S, Rossiter G, Villegas M I.
Sphincter of Oddi manometry in healthy volunteers.
Dig Dis Sci.
1990;
35
38-46
-
6
Lans J L, Parikh N P, Geenen J E.
Application of sphincter of Oddi manometry in routine clinical investigations.
Endoscopy.
1991;
23
139-143
-
7
Rolny P, Geenen J E, Hogan W.
Post-cholecystectomy patients with objective signs of partial bile outflow obstruction: clinical characteristics, sphincter of Oddi manometry findings, and results of therapy.
Gastrointest Endosc.
1993;
39
778-781
-
8
Wehrmann T, Wiemer K, Lembcke B, Jung M.
Effect of endoscopic sphincterotomy on sphincter of Oddi manometry results in patients with or without papillary stenosis.
Z Gastroenterol.
1995;
33
662-668
-
9
American Motility Society.
Position paper: sphincter of Oddi manometry.
Gastrointest Endosc.
1997;
45
342-348
-
10
Ladas S D, Tassios P S, Katsogridakis J. et al .
The clinical need for sphincter of Oddi manometry in gastrointestinal endoscopy units.
Endoscopy.
1993;
25
387-391
-
11
Geenen J E, Hogan W J, Dodds W J. et al .
The efficacy of endoscopic sphincterotomy after cholecystectomy in patients with sphincter of Oddi dysfunction.
N Engl J Med.
1989;
320
82-87
-
12
Toouli J, Roberts-Thomson I C, Kellow J. et al .
Manometry based randomised trial of endoscopic sphincterotomy for sphincter of Oddi dysfunction.
Gut.
2000;
46
98-102
-
13
Botoman V A, Kozarek R A, Novell L A. et al .
Long term outcome after endoscopic sphincterotomy in patients with biliary colic and suspected sphincter of Oddi dysfunction.
Gastrointest Endosc.
1994;
40
165-170
-
14
Bozkurt T, Orth K H, Butsch B, Lux G.
Long term clinical outcome of post-cholecystectomy patients with biliary type pain: results of manometry, non-invasive techniques and endoscopic sphincterotomy.
Eur J Gastroenterol Hepatol.
1996;
8
245-249
-
15
Wehrmann T, Wiemer K, Lembcke B. et al .
Do patients with sphincter of Oddi dysfunction benefit from endoscopic sphincterotomy? A five year prospective trial.
Eur J Gastroenterol Hepatol.
1996;
8
251-256
-
16
Chen J WC, Saccone G TP, Toouli J.
Sphincter of Oddi dysfunction and acute pancreatitis.
Gut.
1998;
43
305-308
-
17
Geenen J E, Nash J A.
The role of sphincter of Oddi manometry and biliary microscopy in evaluating idiopathic recurrent pancreatitis.
Endoscopy.
1998;
30 (Suppl 2)
237-241
-
18
Guelrud M, Plaz J, Mendoza S. et al .
Endoscopic treatment of type II pancreatic sphincter dysfunction [abstract].
Gastrointest Endosc.
1995;
41
398
-
19
Lehman G A, Sherman S.
Hypertensive pancreatic sphincter.
Can J Gastroenterol.
1998;
12
333-337
-
20
Wehrmann T, Zipf A, Caspary W F, Jung M.
Sphincter of Oddi dysfunction in patients with idiopathic recurrent pancreatitis.
Dtsch Med Wochenschr.
1996;
121
781-787
-
21
Gorelick A, Barnett J, Chey W. et al .
Botulinum toxin after biliary sphincterotomy.
Endoscopy.
2004;
35
170-173
-
22
Pasricha P J, Miskovsky E P, Kalloo A N.
Intrasphincteric injection of botulinum toxin for suspected sphincter of Oddi dysfunction.
Gut.
1994;
35
1319-1321
-
23
Muehldorfer S M, Hahn E G, Ell C.
Botulinum toxin as a diagnostic tool of verification of sphincter of Oddi dysfunction causing recurrent pancreatitis.
Endoscopy.
1997;
29
120-124
-
24
Wehrmann T, Seifert H, Seipp M, Lembcke B, Caspary W F.
Endoscopic injection of botulinum toxin for biliary sphincter of Oddi dysfunction.
Endoscopy.
1998;
30
702-707
-
25
Wehrmann T, Schmitt T, Arndt A. et al .
Endoscopic botulinum toxin injection for treatment of idiopathic recurrent pancreatitis due to sphincter of Oddi dysfunction.
Aliment Pharmacol Ther.
2000;
14
1469-1477
-
26
Tarnasky P, Cunningham J, Cotton P. et al .
Pancreatic sphincter hypertension increases the risk of post ERCP-pancreatitis.
Endoscopy.
1997;
29
252-257
-
27
Eversman D, Fogel E L, Rusche M. et al .
Frequency of abnormal pancreatic and biliary sphincter manometry compared with clinical suspicion of sphincter of Oddi dysfunction.
Gastrointest Endosc.
1999;
50
637-641
-
28
Tarnasky P R, Palesch Y Y, Cunningham J T. et al .
Pancreatic stenting prevents pancreatitis after biliary sphincterotomy in patients with sphincter of Oddi dysfunction.
Gastroenterology.
1998;
115
1518-1524
-
29
Okolo P I, Wadwa K, Magee C A. et al .
Immediate reduction of pancreatic SO pressure after endoscopic injection of botulinum toxin (BoTox): implications for prevention of ERCP-induced pancreatitis [abstract].
Gastroenterology.
1998;
114
A535
-
30
Marks J M, Bower A L, Goormastic M. et al .
A comparison of common bile duct pressures after botulinum toxin injection into the sphincter of Oddi versus biliary stenting in a canine model.
Am J Surg.
2001;
181
60-64
-
31
MacKenzie J, Burnstock J, Dolly J O.
The effects of purified botulinum neurotoxin type A on cholinergic, adrenergic and non-adrenergic, atropin-resistant autonomic neuromuscular transmission.
Neuroscience.
1982;
7
997-1006
-
32
Montecucco C, Schiavo G.
Mechanisms of action of tetanus and botulinum neurotoxins.
Molec Microbiol.
1994;
13
1-8
-
33
James A N, Ryan J P, Parkman H P.
Inhibitory effects of botulinum toxin on pyloric and antral smooth muscle.
Am J Physiol.
2003;
285
G291-G297
-
34
Luman W, Pryde A, Heading R C, Palmer K R.
Topical glyceryl trinitrate relaxes the sphincter of Oddi.
Gut.
1997;
40
541-543
-
35
Wehrmann T, Schmitt T, Stergiou N. et al .
Topical application of nitrates onto the papilla of Vater: manometric and clinical results.
Endoscopy.
2001;
33
323-328
-
36
Sudhindran S, Bromwich E, Edwards P R.
Prospective randomized double-blind placebo-controlled trial of glyceryl trinitrate in endoscopic retrograde cholangiopancreatography-induced pancreatitis.
Br J Surg.
2001;
88
1178-1182
-
37
Gorelick A B, Barnett J L, Chey W D. et al .
A study of botulinum toxin injection into the residual pancreatic sphincter after biliary sphincterotomy in patients with sphincter of Oddi dysfunction [abstract].
Gastrointest Endosc.
2001;
53
AB94
-
38
Arguedas M R, Linder J D, Wilcox C M.
Suspected sphincter of Oddi dysfunction type II: empiric biliary sphincterotomy or manometric-guided therapy.
Endoscopy.
2004;
35
174-178
-
39
Lin O S, Soetinho R M, Young H S.
The utility of liver function test abnormalities concomitant with biliary symptoms in predicting a favorable response to endoscopic sphincterotomy in patients with presumed sphincter of Oddi dysfunction.
Am J Gastroenterol.
1998;
93
1833-1836
T. Wehrmann, M. D.
Dept. of Internal Medicine I · Klinikum Hannover-Siloah
Roesebeckstrasse 15 · 30449 Hannover · Germany
Fax: + 49-40-511-9272669
Email: twehrmann@hotmail.com
